Catalent to sell New Jersey facility

Catalent to sell New Jersey facility

(Reuters) – Catalent (NYSE:CTLT) has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on…
Stay defensive with eurozone equities – JPM

Stay defensive with eurozone equities – JPM

Investing.com – The economic activity divergence between the US and the eurozone doesn’t appear to be closing, according to JPMorgan, and thus investors should be wary of buying into a…